Kamada (KMDA) Investment Income (2016 - 2017)
Kamada (KMDA) reported Investment Income of -$236000.0 for Q3 2017, down 122.67% on a YoY basis from $1.0 million in Q3 2016, and down 122.67% quarter-over-quarter from $1.0 million in Q3 2016.
Kamada (KMDA) Investment Income (2016 - 2017) Analysis & Trends
Kamada has reported Investment Income for 2 years, with the latest figure at -$236000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Kamada | 506.10 | -73.15 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -236,000.00 |
| Sep 30, 2016 | 1.04 Mn |